• Sysmex raised its forecast for the six months ending Sept. 30, 2026, citing stronger hematology instrument sales in the Americas, yen weakness.
• Net sales seen at JPY 265 billion, up from JPY 255 billion; operating profit at JPY 25 billion, up from JPY 23 billion.
• Profit before tax forecast at JPY 23 billion versus JPY 21 billion; profit attributable to owners at JPY 15 billion versus JPY 14 billion.
• Full-year net sales forecast lifted to JPY 545 billion from JPY 535 billion; operating profit to JPY 60 billion from JPY 58 billion.
• Full-year profit before tax seen at JPY 56 billion versus JPY 54 billion; profit attributable to owners at JPY 37 billion versus JPY 36 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sysmex Corporation published the original content used to generate this news brief on August 07, 2026, and is solely responsible for the information contained therein.